RecruitingPhase 3NCT07112443
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
Studying Congenital pseudoarthrosis of the tibia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novadip Biosciences
- Intervention
- NVD003(biological)
- Enrollment
- 12 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2025 – 2027
Study locations (6)
- Phoenix Children's Hospital, Inc., Phoenix, Arizona, United States
- Loma Linda University Health, Loma Linda, California, United States
- LifeBridge Health - International Center for Limb Lengthening, Baltimore, Maryland, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cliniques Universitaires Saint-Luc ASBL (CUSCL), Brussels, Brussels Capital, Belgium
- CHU Amiens-Picardie, Amiens, Picardie, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07112443 on ClinicalTrials.gov